Food Additives - Numerical List
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
United States Patent 1191 Lll] 3,983,266 Bahls [451 Sept
United States Patent 1191 lll] 3,983,266 Bahls [451 Sept. 28, 1976 [54] METHOD FOR APPLYING METALLIC 3.776.740 [2/1973 Sivcrz ct al. .......................... .. l06/l SILVER TO A SUBSTRATE OTHER PUBLICATIONS [75] Inventor: Harry Bahls, Wayne, Pa. lvanov et al., Chem. Abs. 43:2548c, I949, [73] Assignee: Peacock Laboratories, Inc., Philadelphia, Pa. Primary Examiner-Ralph S. Kendall [22] Filed: Oct. 9, I974 I 57] ABSTRACT [2!] ,Appl. No.: 513,417 High efficiency deposition of silver on the surface of a substrate is obtained by providing a solution contain [52] [1.8. CI ............................... .. 427/164; 427/165; ing reducible dissolved silver in the presence of an al 427/168; 427/424; 427/426; l06/l kali metal hydroxide and ammonia, all of which are [51] Int. CLZ. ......................................... .. C23C 3/02 applied to the substrate in the presence of an aqueous [58] Field of Search .............. .. l06/l; 427/l68. I69, solution of a moderating reducer containing :1 poly 427/165, I64, 426, 304, 125, 425 hydric alcohol of the formula CH2OH(CHOH),,C H,OH, where n is an integer from 1 to 6. Preferably [56] References Cited the polyhydric alcohol is sorbitol, and in a preferred UNITED STATES PATENTS embodiment a moderator is the form of a thio glycerol is present. 2,996,406 8/l96l Weinrich ........... ............ .. 427/168 3,772,078 ll/l973 Polichcttc ct al ................. .. l06/l X l5 Claims, No Drawings 3,983,266 1 Other objects and advantages of this invention, in METHOD FOR APPLYING METALLIC SILVER TO cluding the economy of the same, and the case with A SUBSTRATE which it may be applied to existing silver coating equip ment and apparatus, will further become apparent BRIEF SUMMARY OF THE INVENTION 5 hereinafter. -
(12) Patent Application Publication (10) Pub. No.: US 2005/0124724 A1 Burton Et Al
US 2005O124724A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2005/0124724 A1 Burton et al. (43) Pub. Date: Jun. 9, 2005 (54) POLYMER COMPOSITIONS WITH (21) Appl. No.: 10/728,439 BIOACTIVE AGENT, MEDICAL ARTICLES, AND METHODS (22) Filed: Dec. 5, 2003 (75) Inventors: Scott A. Burton, Woodbury, MN (US); Publication Classification Patrick D. Hyde, Burnsville, MN (US); Prabhakara S. Rao, Maplewood, MN (51) Int. Cl." ....................................................... C08K 3/00 (US); Caroline M. Ylitalo, Stillwater, (52) U.S. Cl. .............................................................. 523/122 MN (US) (57) ABSTRACT Correspondence Address: A polymer composition that includes a hydrophilic polymer, 3M INNOVATIVE PROPERTIES COMPANY an optional Secondary organic polymer, and a bioactive PO BOX 33427 agent distributed therein, wherein the bioactive agent is ST. PAUL, MN 55133-3427 (US) Selected from the group consisting of a Silver compound, a copper compound, a Zinc compound, and combinations (73) Assignee: 3M Innovative Properties Company thereof. US 2005/O124724 A1 Jun. 9, 2005 POLYMER COMPOSITIONS WITH BOACTIVE comprising absorbent hydrophilic microparticles, a metal AGENT, MEDICAL ARTICLES, AND METHODS compound Selected from the group consisting of a Silver compound, a copper compound, a Zinc compound, and BACKGROUND combinations thereof, wherein the Silver compound has a 0001 Polymer compositions that include bioactive Solubility of at least 0.1 gram per liter in water; and a agents (e.g., antimicrobial agents) are used for a variety of hydroxide Source that converts the metal compound to the applications, particularly medical applications Such as corresponding metal oxide. The components are combined wound dressings and wound packing materials. Conven in a manner to incorporate the metal oxide within the tional antimicrobial agents include ionizable Silver com microparticles. -
Biochemistry Lab (BT35L) Lab Manual
Department of Biotechnology Sri Jayachamarajendra College of Engineering Mysuru-570006 Biochemistry Lab (BT35L) Lab Manual (Prepared by Dr. S. Nanjunda Swamy and Dr. M. N. Nagendra Prasad) INDEX 1. PREPARATION OF SODIUM ACETATE BUFFER 2. ESTIMATION OF GLUCOSE BY DNS METHOD 3. ESTIMATION OF SAPONIFICATION VALUE OF FATS/OILS 4. ESTIMATION OF ACID VALUE OF FATS/OILS 5. PREPARATION OF PHOSPHOTIDYL CHOLINE FROM EGG YOLK 6. LOWRY METHOD FOR PROTEIN ESTIMATION 7. ESTIMATION OF AMINO ACID BY FORMAL TITRATION 8. DETERMINATION OF ISOELECTRIC POINT OF GLYCINE (PI) 9. SEPARATION OF AMINO ACIDS BY CIRCLULAR PAPER CHROMATOGRAPHY 10. ESTIMATION OF IRON BY WONG’S METHOD Experiment No 1: PREPARATION OF SODIUM ACETATE BUFFER Aim: Preparation of sodium acetate buffer of 0.1M and 4.7 pH (25ml) Principle: Buffer is a solution used to maintain the pH of any biochemical reaction. Procedure: 1. Weigh about 0.205g of sodium acetate. Dissolve it in 15ml distilled water. 2. Dip the electrode of the pre calibrated pH meter in the above solution. 3. Add acetic acid of 0.5M drop by drop till the pH reaches 4.7. 4. Make up the solution to 25ml with distilled water. 5. Store the buffer in a sealed container. Experiment No 2: ESTIMATION OF GLUCOSE BY DNS METHOD Aim: To estimate the amount of glucose in the given ample by DNS method. Principle: This method tests for the presence of free carbonyl group (C=O), of the reducing sugars. The reaction involves the oxidation of this of free carbonyl group (aldehyde functional group present in, glucose and the ketone functional group in fructose) and simultaneous reduction of , 3,5-dinitrosalicylic acid to 3-amino,5- nitrosalicylic acid (a coloured molecule) under alkaline conditions. -
Notices Federal Register Vol
28416 Notices Federal Register Vol. 62, No. 100 Friday, May 23, 1997 This section of the FEDERAL REGISTER 1255 22nd Street, NW, Room 311, West interests of consumers. Through contains documents other than rules or End Court Building, Washington, DC adoption of food standards, codes of proposed rules that are applicable to the 20250±3700; (202) 418±8852. For practice, and other guidelines public. Notices of hearings and investigations, information pertaining to particular developed by its committees and by committee meetings, agency decisions and committees, the delegate of that promoting their adoption and rulings, delegations of authority, filing of petitions and applications and agency committee may be contacted. (A implementation by governments, Codex statements of organization and functions are complete list of U.S. delegates and seeks to ensure that the world's food examples of documents appearing in this alternate delegates can be found in supply is sound, wholesome, free from section. Appendix 1 to this notice.) adulteration, and correctly labeled. In SUPPLEMENTARY INFORMATION: the United States, the United States Department of Agriculture (USDA); the DEPARTMENT OF AGRICULTURE Background Food and Drug Administration (FDA), The World Trade Organization (WTO) Department of Health and Human Food Safety and Inspection Service was established on January 1, 1995, as Services (HHS), and the Environmental [Docket No. 97±026N] the common international institutional Protection Agency (EPA) manage and framework for the conduct of trade carry out U.S. Codex activities. International Standard-Setting relations among its members in matters As the agency responsible for Activities related to the Uruguay Round informing the public of the sanitary and Agreements. -
Method for Producting L-Aspartic Acid
Europiisches Patentamt (19) J European Patent Office © Publication number: 0 129 119 Office europeen des brevets A2 © EUROPEAN PATENT APPLICATION © Application number: 84106218.5 ©Int CI.3: C 12 N 15/00 C 12 P 13/20, C 12 N 1/20 @ Date of filing: 30.05.84 C 12 N 9/88 //(C12N1/20,C12R1/19), (C12P13/20,C12R1/19) © Priority: 15.06.83 JP 107573/83 © Applicant: Tanabe Seiyaku Co., Ltd. No. 21 Dosho-machi 3-chome Higashi-ku Osaka-shi Osaka-fu(JP) © Date of publication of application: 27.12.84 Bulletin 84/52 © Inventor: KisumLMasahiko No. 12-20, Morikitacho4-chome Higashinada-ku © Designated Contracting States: Kobe-shi Hyogo-ken(JP) CH DE FR GB U SE © Inventor: Komatsubara,Saburo No. 385-10, Kamigasacho Kusatsu-shi Shiga-ken(JP) © Inventor: Taniguchi, Tomoyasu No. 12-22, Kawaharacho Izumiotsu-shi Osaka-fu(JP) © Representative: Kraus, Walter, Dr. et al, Patentanwalte Kraus, Weisert & Partner Irmgardstrasse 15 D-8000 Munchen 71 (DE) © Method for producing L-aspartic acid. A novel microorganism of the genus Escherichia contain- ing a hybrid plasmid prepared by integrating a plasmid with a deoxyribonucleic acid carrying the gene for aspartase which is obtained from a microorganism of the genus Escherichia. An industrially advantageous method for producing L-aspartic acid comprising contacting a culture of the novel microorganism, microbial cells collected from the culture or a processed material of the microbial cells with fumaric acid and ammonia to produce L-aspartic acid and then collecting L-aspartic acid thus produced is also disclosed. < 0> FIELD OF THE INVENTION The present invention relates to a novel micro- organism of the genus Escherichia having high aspartase activity and a method for producing L-aspartic acid using the microorganism. -
Low Acyl Gellan Gum for Inclusion on the National List of Substances Allowed in Organic Production and Handling (7 CFR 205.605 (B)
Petition for Evaluation of Low Acyl Gellan Gum for Inclusion on the National List of Substances Allowed in Organic Production and Handling (7 CFR 205.605 (b) Submitted by: CP Kelco U.S., Inc. 3100 Cumberland Blvd., Suite 600 Atlanta, GA 30339 Date: 08 August 2019 CP Kelco U.S., Inc. 08 August 2019 National Organic List Petiion Low Acyl Gellan Gum Table of Contents Item A.1 — Section of National List ........................................................................................................... 4 Item A.2 — OFPA Category - Crop and Livestock Materials .................................................................... 4 Item A.3 — Inert Ingredients ....................................................................................................................... 4 1. Substance Name ................................................................................................................................... 5 2. Petitioner and Manufacturer Information ............................................................................................. 5 2.1. Corporate Headquarters ................................................................................................................5 2.2. Manufacturing/Processing Facility ...............................................................................................5 2.3. Contact for USDA Correspondence .............................................................................................5 3. Intended or Current Use .......................................................................................................................5 -
Disposal of Solid Chemicals in the Normal Trash
Disposal of Solid Chemicals in the Normal Trash Many solid chemicals can be safety discarded into the normal trash, provided they are in containers that are not broken or cracked and have tightly fitting caps. These chemicals are considered acceptable for ordinary disposal because they display none of the properties of hazardous waste, are of low acute toxicity, and have not been identified as having any chronic toxic effects as summarized in the National Institute of Occupational Safety and Health (NIOSH) “Registry of Toxic Effects of Chemical Substances”. Examples of chemicals acceptable for disposal as regular trash are listed below. To dispose of these chemicals, place the containers in a box lined with a plastic bag, tape the top of the box shut, write “Normal Trash” on the box and then place the box next to the lab trash container. Only solid forms of these chemicals can be disposed in this manner. Any questions about these chemicals or other chemicals that may be disposed of in the normal trash should be directed to the Hazardous Materials Technician (610) 330-5225. Chemicals Generally Acceptable for Disposal as Regular Trash Acacia powder, gum Detergent (most) Methyl salicylate Sodium carbonate arabic Cation exchange resins Methylene blue Sodium chloride Acid, Ascorbic Chromatographic Methyl stearate Sodium citrate Acid, Benzoic absorbents Nutrient agar Sodium dodecyl sulfate Acid, Boric Crystal violet Octacosane (SDS) Acid, Casamind Dextrin Parafin Sodium formate Acid, Citric Dextrose Pepsin Sodium iodide Acid, Lactic Diatomaceous -
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01 -
Dietary Supplements Compendium Volume 1
2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs . -
Official Journal of the European Communities No L 61/1
18 . 3 . 95 EN Official Journal of the European Communities No L 61/1 I (Acts whose publication is obligatory) EUROPEAN PARLIAMENT AND COUNCIL DIRECTIVE No 95/2/EC of 20 February 1995 on food additives other than colours and sweeteners THE EUROPEAN PARLIAMENT AND THE COUNCIL OF Whereas it is necessary to lay down strict rules for the THE EUROPEAN UNION, use of food additives in infant formulae, follow-on formulae and weaning foods, as referred to in Council Having regard to the Treaty establishing the European Directive 89/398/EEC of 3 May 1989 on the Community, and in particular Article 100a thereof, approximation of the laws of the Member States relating to foodstuffs intended for particular nutritional uses ( 5 ), Having regard to the proposal from the Commission ( 1 ), and in particular Article 4(1 ) ( e ) thereof; Having regard to the opinion of the Economic and Social Whereas this Directive is not intended to affect rules Committee ( 2 ), relating to sweeteners and colours; Acting in accordance with the procedure laid down in Whereas, pending specific provisions pursuant to Council Article 189b of the Treaty ( 3 ), Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market ( 6 ), Having regard to the Council Directive 89/107/EEC of and pursuant to Council Directive 90/642/EEC of 21 December 1988 on the approximation of the laws of 27 November 1990 on the fixing of maximum levels for the Member States concerning food additives authorized pesticide residues in and on certain products of plant -
Anti-Aging Med Peel Ingredients AHA 30 % Kojic Skin Lightening Peel
Anti-Aging Med Peel Ingredients AHA 30 % Kojic Skin Deionized Water, Glycolic Acid, Lactic Acid, Kojic Acid, Licorice Extract, Lightening Peel Kit - Light Bearberry Extract, Citric Acid, Malic Acid, Sodium Lactate, Sodium Hydroxide, Strength-2 fl oz/60 ml- Xanthan Gum, Phenoxyethanol, Caprylyl Glycol, Potassium Sorbate, Hexylene 022099716075 Glycol. Peel: Deionized Water, Glycolic Acid, Sodium Hydroxide, Xanthan Gum, Phenoxyethanol, Caprylyl Glycol, Potassium Sorbate, Hexylene Glycol. Peel Prep: Isopropyl Alcohol, Deionized Water, Malic Acid, Green Tea Extract, Phenoxyethanol, Caprylyl Glycol, Potassium Sorbate, Hexylene Glycol. Set-Glycolic *30% Anti Aging Neutralizer Solution: Distilled Water, Glycerine, Propylene Glycol, Sodium Peel Kit - Light Strength- Bicarbonate, Cellulose Gum, Benzalkonium Chloride, Phenoxyethanol, Caprylyl 022099716143 Glycol, Potassium Sorbate, Hexylene Glycol. Hyaluronic *Replenish Serum- Deionized Water, Hyaluronic Acid, Phenoxyethanol, Caprylyl Glycol, Potassium 2 fl oz/60 ml-22099716211 Sorbate, Hexylene Glycol. Fusion Peel Ingredients: Deionized Water, Isopropyl Alcohol, Trichloracetic Acid, Lactic Acid, Salicylic Acid, Resorcinol, Glycolic Acid, Papaya Enzyme, Pumpkin Enzyme, Pineapple Enzyme, L-ascorbic Acid, Cellulose Gum, Phenoxyethanol, Caprylyl Glycol, Potassium Sorbate, Hexylene Glycol. Hyaluronic Anti Aging Set-At *Home Fusion Peel and Serum : Ingredients: Deionized Water, Hyaluronic Acid, Phenoxyethanol, SPF30-610373405328 Caprylyl Glycol, Potassium Sorbate, Hexylene Glycol. Serum: Deionized Water, -
Alphabetical Listing of ATC Drugs & Codes
Alphabetical Listing of ATC drugs & codes. Introduction This file is an alphabetical listing of ATC codes as supplied to us in November 1999. It is supplied free as a service to those who care about good medicine use by mSupply support. To get an overview of the ATC system, use the “ATC categories.pdf” document also alvailable from www.msupply.org.nz Thanks to the WHO collaborating centre for Drug Statistics & Methodology, Norway, for supplying the raw data. I have intentionally supplied these files as PDFs so that they are not quite so easily manipulated and redistributed. I am told there is no copyright on the files, but it still seems polite to ask before using other people’s work, so please contact <[email protected]> for permission before asking us for text files. mSupply support also distributes mSupply software for inventory control, which has an inbuilt system for reporting on medicine usage using the ATC system You can download a full working version from www.msupply.org.nz Craig Drown, mSupply Support <[email protected]> April 2000 A (2-benzhydryloxyethyl)diethyl-methylammonium iodide A03AB16 0.3 g O 2-(4-chlorphenoxy)-ethanol D01AE06 4-dimethylaminophenol V03AB27 Abciximab B01AC13 25 mg P Absorbable gelatin sponge B02BC01 Acadesine C01EB13 Acamprosate V03AA03 2 g O Acarbose A10BF01 0.3 g O Acebutolol C07AB04 0.4 g O,P Acebutolol and thiazides C07BB04 Aceclidine S01EB08 Aceclidine, combinations S01EB58 Aceclofenac M01AB16 0.2 g O Acefylline piperazine R03DA09 Acemetacin M01AB11 Acenocoumarol B01AA07 5 mg O Acepromazine N05AA04